10 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33275878 | Advantages of brain penetrating inhibitors of kynurenine-3-monooxygenase for treatment of neurodegenerative diseases. | 2021 Jan 15 | 1 |
2 | 32148781 | Kynurenine-3-monooxygenase: A new direction for the treatment in different diseases. | 2020 Feb | 2 |
3 | 27245499 | The kynurenine pathway in schizophrenia and bipolar disorder. | 2017 Jan | 2 |
4 | 28187857 | Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders. | 2017 Nov 15 | 1 |
5 | 25540092 | Etiological classification of depression based on the enzymes of tryptophan metabolism. | 2014 Dec 24 | 2 |
6 | 21693093 | Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls. | 2012 Jan | 1 |
7 | 19226371 | On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo. | 2009 Apr | 4 |
8 | 15206781 | Modulation of the kynurine pathway of tryptophan metabolism in search for neuroprotective agents. Focus on kynurenine-3-hydroxylase. | 2003 | 1 |
9 | 12354294 | Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures. | 2002 Sep | 2 |
10 | 8906269 | Kynurenic acid-enhancing and anti-ischemic effects of the potent kynurenine 3-hydroxylase inhibitor FCE 28833 in rodents. | 1996 | 1 |